CME Operating Cycle from 2010 to 2026
| CME Stock | USD 308.09 4.18 1.38% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 35.78014293 | Current Value 43.66 | Quarterly Volatility 4.34597316 |
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME's main balance sheet or income statement drivers, such as Depreciation And Amortization of 447.5 M, Interest Expense of 116.3 M or Selling And Marketing Expenses of 1.09, as well as many indicators such as Price To Sales Ratio of 8.36, Dividend Yield of 0.0238 or PTB Ratio of 3.78. CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
CME | Operating Cycle | Build AI portfolio with CME Stock |
Analyzing CME's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing CME's current valuation and future prospects.
Latest CME's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of CME Group over the last few years. It is CME's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CME's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
CME Operating Cycle Regression Statistics
| Arithmetic Mean | 37.49 | |
| Geometric Mean | 37.27 | |
| Coefficient Of Variation | 11.59 | |
| Mean Deviation | 3.34 | |
| Median | 36.02 | |
| Standard Deviation | 4.35 | |
| Sample Variance | 18.89 | |
| Range | 14.665 | |
| R-Value | (0.12) | |
| Mean Square Error | 19.85 | |
| R-Squared | 0.01 | |
| Significance | 0.64 | |
| Slope | (0.10) | |
| Total Sum of Squares | 302.20 |
CME Operating Cycle History
About CME Financial Statements
CME stakeholders use historical fundamental indicators, such as CME's Operating Cycle, to determine how well the company is positioned to perform in the future. Although CME investors may analyze each financial statement separately, they are all interrelated. For example, changes in CME's assets and liabilities are reflected in the revenues and expenses on CME's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CME Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 35.78 | 43.66 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out the analysis of CME Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Financial Exchanges & Data sector continue expanding? Could CME diversify its offerings? Factors like these will boost the valuation of CME. Projected growth potential of CME fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CME data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.35 | Dividend Share 5 | Earnings Share 11.15 | Revenue Per Share | Quarterly Revenue Growth 0.083 |
CME Group's market price often diverges from its book value, the accounting figure shown on CME's balance sheet. Smart investors calculate CME's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CME's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CME's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CME should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.